His second line of “but all the beneficial ones haven’t had time to become ubiquitous” reveals a weird misunderstanding of how evolution works. Not all beneficial mutations would necessarily ever become “ubiquitous”. And few if any mutations, especially on the scale of a single nucleotide, could fairly be characterized as objectively and universally “beneficial”. Environment and context is crucial.
Take the example of sickle cell disease, which can be caused by a single nucleotide mutation. It can cause many problems in its sufferers but it can also confer its carrier with resistance to malaria. Whether its a beneficial mutation depends entirely on the environment, from prevalence of malaria to availability of treatment for the various symptoms.